Saturday, July 11, 2026

Drug profile · INN

abacavir + lamivudine

abacavir + lamivudine (ABACAVIR/LAMIVUDINE VIATRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — abacavir + lamivudine

Quick answer

abacavir + lamivudine (ABACAVIR/LAMIVUDINE VIATRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN abacavir + lamivudine
Brand ABACAVIR/LAMIVUDINE VIATRIS

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Dolutegravir/abacavir/lamivudine FDC Phase 3 · ViiV Healthcare · Infection, Human Immunodeficiency Virus

Frequently asked questions

What is abacavir + lamivudine?

abacavir + lamivudine (ABACAVIR/LAMIVUDINE VIATRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for abacavir + lamivudine?

ABACAVIR/LAMIVUDINE VIATRIS is a marketed brand name for abacavir + lamivudine. Check FDA Drugs@FDA for the current US label holder and prescribing information.